Login / Signup

Survival and pleurodesis outcome in patients with malignant pleural effusion - a systematic review.

Maged HassanElinor HarrissRachel M MercerNajib M Rahman
Published in: Pleura and peritoneum (2021)
Malignant pleural effusion (MPE) is a common condition that presents with progressive breathlessness. Long term solutions are often required due to recurrence of effusion after simple drainage. Pleurodesis is one of the main options resorted to for long term control of MPE. There is data to suggest there may be a survival benefit for patients with MPE who achieve successful pleurodesis. A systematic review was carried out to explore this correlation and results suggest that there could be a survival difference according to pleurodesis outcome in patients with MPE. Fifteen studies (reported in 13 papers) were included; 13 (86.6%) of the studies showed survival difference in favour of pleurodesis success. The median [interquartile range] difference in survival between the two groups among the different studies was five [3.5-5.8] months. Most of the included studies suffered moderate to severe risk of bias and, thus, large prospective studies of patients undergoing pleurodesis are required to ascertain this effect.
Keyphrases
  • free survival
  • case control
  • patients undergoing
  • machine learning
  • electronic health record
  • drug induced